Zobrazeno 1 - 10
of 92
pro vyhledávání: '"E. Mezzenga"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Silvia Asioli, Andrea Bettinelli, Anna Fedeli, Emiliano Loi, Federica Matteucci, Irene Azzali, Anna Sarnelli, M.L. Belli, Lorenzo Fantini, Giovanni Paganelli, Giacomo Feliciani, E. Mezzenga
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
PurposeThe objective of this study was to evaluate a set of radiomics-based advanced textural features extracted from 18F-FLT-PET/CT images to predict tumor response to neoadjuvant chemotherapy (NCT) in patients with locally advanced breast cancer (B
Autor:
A. Bettinelli, M. Avanzo, E. Loi, F. Marturano, E. Menghi, E. Mezzenga, G. Pirrone, A. Sarnelli, L. Strigari, S. Strolin, M. Paiusco
Publikováno v:
Physica Medica. 92:S14-S15
Autor:
Giovanni Bellomo, Christopher Palestro, Anna Sarnelli, Kenneth Nichols, Frank P. DiFilippo, E. Mezzenga
Publikováno v:
Applied Sciences; Volume 12; Issue 5; Pages: 2726
Background: Conspicuous concentric ring artifacts in phantom reconstructions triggers retuning SPECT systems. These evaluations are visual, not quantitative. Our study was undertaken to determine the degree to which observers agree about SPECT concen
Autor:
Anna Sarnelli, Marta Cremonesi, M.L. Belli, Stefano Severi, Antonino Romeo, Giovanni Paganelli, Federica Matteucci, Silvia Nicolini, E. Mezzenga, Francesco Cesarini, Paola Caroli, Lidia Strigari, Valentina Di Iorio
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology
Frontiers in Oncology
Radioligand therapy is a type of internal radiotherapy combining a short-range radioisotope labeled to a carrier with a high affinity for a specific receptor expressed on tumor cells. Targeted alpha therapy (TAT) combines a high-linear energy transfe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0c85f2378bd8ce792709908d1bbaefe
https://hdl.handle.net/11392/2427058
https://hdl.handle.net/11392/2427058
Autor:
M.L. Belli, E. Mezzenga, F. Cesarini, P. Caroli, V. Di Iorio, M. Cremonesi, L. Strigari, A. Romeo, S. Nicolini, F. Matteucci, S. Severi, G. Paganelli, A. Sarnelli
Publikováno v:
Physica Medica. 92:S89
Autor:
E. Mezzenga, M.L. Belli, A. Vagheggini, G. Feliciani, F. Monti, M. Cremonesi, G. Paganelli, A. Sarnelli
Publikováno v:
Physica Medica. 92:S53
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marco Antonio Sarti, T. Paulus, Valentina Ferri, Michele Iori, Federica Fioroni, Angelina Filice, Elisa Grassi, Annibale Versari, E. Mezzenga, Nico Lanconelli
Publikováno v:
Physica Medica. 31:72-79
Background Targeted radionuclide therapy is a rapidly growing modality. A few commercial treatment planning systems are entering the market. However, some in-house systems are currently developed for a more flexible and customized dosimetry calculati
Autor:
Annibale Versari, Domenico Finocchiaro, Marco Antonio Sarti, Elisa Grassi, Federica Fioroni, Michele Iori, E. Mezzenga, Filice A
The purpose of this study was to investigate the influence of the Ordered Subsets Expectation Maximization (OSEM) reconstruction updates implemented in the 177Lu SPECT/CT imaging processing in molecular radiotherapy. A NEMA IEC Body PhantomTM was use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fef361faffaaf4f97e721008f2877ce3
http://hdl.handle.net/11585/726097
http://hdl.handle.net/11585/726097